rs17021918

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -12 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_Strong

The NM_006457.5(PDLIM5):c.1283+1276C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.299 (AC=45,484) in the gnomAD database across 151,968 control chromosomes, including 7,112 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.347. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.30 ( 7112 hom., cov: 33)

Consequence

PDLIM5
NM_006457.5 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.02

Publications

118 publications found
Variant links:
Genes affected
PDLIM5 (HGNC:17468): (PDZ and LIM domain 5) This gene encodes a member of a family of proteins that possess a 100-amino acid PDZ domain at the N terminus and one to three LIM domains at the C-terminus. This family member functions as a scaffold protein that tethers protein kinases to the Z-disk in striated muscles. It is thought to function in cardiomyocyte expansion and in restraining postsynaptic growth of excitatory synapses. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jan 2012]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_006457.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript

Our verdict: Benign. The variant received -12 points.

BP4
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Strong).
BA1
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.3467 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_006457.5. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PDLIM5
NM_006457.5
MANE Select
c.1283+1276C>T
intron
N/ANP_006448.5Q96HC4-1
PDLIM5
NM_001256426.2
c.1370+1276C>T
intron
N/ANP_001243355.2Q96HC4-6
PDLIM5
NM_001011513.4
c.956+1276C>T
intron
N/ANP_001011513.4Q96HC4-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PDLIM5
ENST00000317968.9
TSL:1 MANE Select
c.1283+1276C>T
intron
N/AENSP00000321746.4Q96HC4-1
PDLIM5
ENST00000615540.4
TSL:1
c.1370+1276C>T
intron
N/AENSP00000480359.1Q96HC4-6
PDLIM5
ENST00000542407.5
TSL:1
c.956+1276C>T
intron
N/AENSP00000442187.2Q96HC4-4

Frequencies

GnomAD3 genomes
AF:
0.299
AC:
45454
AN:
151848
Hom.:
7101
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.219
Gnomad AMI
AF:
0.246
Gnomad AMR
AF:
0.283
Gnomad ASJ
AF:
0.316
Gnomad EAS
AF:
0.349
Gnomad SAS
AF:
0.190
Gnomad FIN
AF:
0.331
Gnomad MID
AF:
0.258
Gnomad NFE
AF:
0.350
Gnomad OTH
AF:
0.321
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.299
AC:
45484
AN:
151968
Hom.:
7112
Cov.:
33
AF XY:
0.298
AC XY:
22120
AN XY:
74280
show subpopulations
African (AFR)
AF:
0.219
AC:
9090
AN:
41478
American (AMR)
AF:
0.283
AC:
4316
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.316
AC:
1095
AN:
3468
East Asian (EAS)
AF:
0.349
AC:
1795
AN:
5146
South Asian (SAS)
AF:
0.191
AC:
920
AN:
4824
European-Finnish (FIN)
AF:
0.331
AC:
3491
AN:
10548
Middle Eastern (MID)
AF:
0.269
AC:
79
AN:
294
European-Non Finnish (NFE)
AF:
0.350
AC:
23805
AN:
67930
Other (OTH)
AF:
0.317
AC:
669
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1637
3274
4912
6549
8186
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
458
916
1374
1832
2290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.336
Hom.:
31941
Bravo
AF:
0.293
Asia WGS
AF:
0.229
AC:
795
AN:
3472

Local populations

ToMMo 61KJPN (+60KJPN MNV)
AF:
0.373
AC:
45676
AN:
122552
Turkish Variome
AF:
0.329
AC:
508
AN:
1546
Hom.:
80
WBBC (Westlake BioBank for Chinese) pilot
AF:
0.343
AC:
3069
AN:
8960
Hom.:
542
ABraOM SABE-WGS-1171
AF:
0.311
AC:
728
AN:
2342
Hom.:
111

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
3.9
DANN
Benign
0.58
PhyloP100
-1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.